Repligen Corporation (RGEN) Financials
RGEN Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 2.9 billion | 825.3 million |
| Dec. 31, 2025 | 2.9 billion | 843.6 million |
| Sept. 30, 2025 | 2.9 billion | 840.6 million |
| June 30, 2025 | 2.9 billion | 839.9 million |
RGEN Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | 23.3 million | ? |
| Dec. 31, 2025 | 17.0 million | 8.0 million |
| Sept. 30, 2025 | 42.7 million | 9.0 million |
| June 30, 2025 | 21.0 million | 8.4 million |
RGEN Net Income
No data available :(
RGEN Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 784.5 million | 546.6 million | 120.0 million |
| Dec. 31, 2025 | 767.6 million | 542.2 million | 126.2 million |
| Sept. 30, 2025 | 748.7 million | 537.9 million | 150.9 million |
| June 30, 2025 | 708.9 million | 533.7 million | 152.3 million |
RGEN Shares Outstanding
RGEN Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | 4.9 million | 14.5 million | 76.5 million | - |
| Dec. 31, 2025 | 8.7 million | 12.2 million | 62.7 million | - |
| Sept. 30, 2025 | 5.4 million | 14.2 million | 73.7 million | - |
| June 30, 2025 | 7.6 million | 14.0 million | 71.2 million | - |
RGEN Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | 194.3 million | 95.8 million |
| Dec. 31, 2025 | 197.9 million | 104.5 million |
| Sept. 30, 2025 | 188.8 million | 88.3 million |
| June 30, 2025 | 182.4 million | 91.2 million |
RGEN Revenue by Segment
Graph available only for paid members. Upgrade to see it.
RGEN
Price: $122.31
52 week price:
Earnings Per Share: 0.91 USD
P/E Ratio: 127.37
Exchange: NMS
Sector: Healthcare
Industry: Medical Instruments & Supplies
Country: United States
Volume: 633600
Ebitda: 2.7 millionMarket Capitalization: 6.9 billion